Recent updates on anti-viral drug design against covid – 19 using suitable enzyme targets
International Journal of Pharmaceutical Sciences Review and Research
; 62(2):184-189, 2020.
Article
in English
| EMBASE | ID: covidwho-682121
ABSTRACT
Severe acute respiratory disorder corona virus 2 (SARS-CoV-2) is a recently developing human irresistible corona virus that causes COVID-19, which has been perceived as a pandemic by the World Health Organization (WHO) on March eleventh. It is a significant wellspring of fiasco in 21st century. There is still no immunization, no complete treatment for this infection since its pathogenesis and multiplication pathways are as yet obscure. The endeavors of universal wellbeing specialists have since concentrated on Rapid determination and disengagement of patients just as the quest for treatments ready to counter the most genuine impacts of the illness. This sickness or infection presents an unpredicted test to recognize powerful medication for anticipation and treatment. In any case, the absence of explicit medications to forestall or treat an attack is a significant need at this present purpose of time. In such manner, we led an efficient audit to recognize major druggable target in coronavirus.
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
International Journal of Pharmaceutical Sciences Review and Research
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS